メタ情報
| meta description平均長 | 140 |
|---|
| OGPありページ数 | 30 |
|---|
| Twitterカードありページ数 | 30 |
|---|
内部リンク分析(Internal)
| ユニーク内部リンク数 | 91 |
|---|
| ページあたり内部リンク平均 | 29.43 |
|---|
連絡先候補(Contacts)
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| Quanterix | 1 |
| Akoya | 0.721931 |
| Acquired | 0.639828 |
| Promptly | 0.566038 |
| Nimble | 0.529416 |
| AbbVie | 0.450249 |
| will | 0.432829 |
| EditCo | 0.426552 |
| transaction | 0.417116 |
| patient | 0.386998 |
| proposed | 0.379157 |
| Rapid | 0.35546 |
| statements | 0.339623 |
| develops | 0.331762 |
| any | 0.304815 |
| Argonaut | 0.304815 |
| other | 0.294809 |
| SEC | 0.284368 |
| forward | 0.266732 |
| n6 | 0.264151 |
| statement | 0.260671 |
| may | 0.256687 |
| research | 0.239437 |
| looking | 0.238655 |
| iconPCR | 0.226415 |
| acquired | 0.226415 |
| com | 0.216701 |
| company | 0.216701 |
| fill | 0.213276 |
| MDprospects | 0.213276 |
| proxy | 0.213276 |
| platform | 0.21181 |
| Hill | 0.210676 |
| peptide | 0.207547 |
| Tec | 0.207547 |
| development | 0.206669 |
| Telegraph | 0.204292 |
| Partners | 0.204292 |
| our | 0.201324 |
| its | 0.198099 |
| products | 0.196539 |
| services | 0.196539 |
| provides | 0.192515 |
| finish | 0.189579 |
| Magstim | 0.189579 |
| Flynn | 0.189579 |
| discovery | 0.187257 |
| new | 0.187257 |
| their | 0.183706 |
| which | 0.182501 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Montgomery | Street | 4.579944 | 120 |
| Hill | Telegraph | 4.335261 | 130 |
| Hill | Partners | 4.155249 | 126 |
| Street | Suite | 3.9569 | 90 |
| Montgomery | Suite | 3.76734 | 90 |
| Francisco | San | 3.559198 | 58 |
| generation | next | 3.542153 | 48 |
| looking | statements | 3.457708 | 60 |
| life | science | 3.404518 | 68 |
| Partners | Telegraph | 3.368402 | 94 |
| proposed | transaction | 3.33464 | 64 |
| Tec | n6 | 3.22803 | 41 |
| San | Suite | 3.148921 | 60 |
| fill | finish | 3.129414 | 32 |
| San | Street | 3.112042 | 60 |
| forward | looking | 3.081502 | 52 |
| proxy | statement | 3.03425 | 33 |
| Chief | Officer | 3.028466 | 36 |
| Montgomery | San | 2.954055 | 60 |
| President | Vice | 2.835165 | 24 |
| generation | sequencing | 2.76475 | 28 |
| risks | uncertainties | 2.716965 | 20 |
| Agena | Bioscience | 2.716965 | 20 |
| Capital | NewVale | 2.701535 | 19 |
| preparation | sample | 2.674594 | 24 |
| joint | proxy | 2.646849 | 24 |
| differ | materially | 2.624762 | 16 |
| long | term | 2.624762 | 16 |
| Nimble | Therapeutics | 2.607459 | 46 |
| Life | Technologies | 2.586933 | 24 |
| visit | www | 2.566477 | 32 |
| com | www | 2.555144 | 51 |
| Chief | Executive | 2.523882 | 22 |
| engagement | patient | 2.507092 | 40 |
| forward | statements | 2.50498 | 40 |
| prospectus | statement | 2.500312 | 23 |
| common | stock | 2.475171 | 16 |
| Experience | Patient | 2.472053 | 20 |
| Executive | Officer | 2.443306 | 21 |
| autoimmune | diseases | 2.435378 | 16 |
| MDidentity | Referify | 2.416311 | 16 |
| Appointec | Referify | 2.416311 | 16 |
| Manufacturing | Services | 2.385947 | 15 |
| paradigm | shifting | 2.38478 | 12 |
| massively | parallel | 2.38478 | 12 |
| Chemistry | Medicinal | 2.38478 | 12 |
| sensitive | ultra | 2.38478 | 12 |
| Akoya | Quanterix | 2.364303 | 85 |
| joint | statement | 2.345139 | 21 |
| Magstim | Rapid | 2.33614 | 24 |